Skip to main content
Zomedica Corp. (ZOM)
NYSEAMERICAN: ZOM · IEX Real-Time Price · USD
0.148
-0.002 (-1.40%)
At close: Jul 19, 2024, 4:00 PM
0.158
+0.010 (6.42%)
Pre-market: Jul 22, 2024, 7:06 AM EDT

Zomedica Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Zomedica.

Analyst Consensus: n/a
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

There are currently no analyst ratings available for Zomedica.

Recommendation Trends

Rating Jan '23
Strong Buy 0
Buy 0
Hold 0
Sell 0
Strong Sell 0
Total 0

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Jason Kolbert
Dawson James
 Dawson James
Strong Buy
Initiates
$6
 Strong Buy Initiates $6 +3,954.05% Jan 6, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
34.44M
from 25.19M
Increased by 36.75%
Revenue Next Year
39.58M
from 34.44M
Increased by 14.92%
EPS This Year
-0.01
from -0.04
EPS Next Year
n/a
from -0.01
Year 20192020202120222023202420252026
Revenue
--4.13M18.93M25.19M34.44M39.58M50.07M
Revenue Growth
---358.02%33.05%36.75%14.92%26.51%
EPS
-0.19-0.05-0.05-0.02-0.04-0.01--
EPS Growth
--------
Forward PE
--------
No. Analysts -----222
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 35.8M 41.1M 52.1M
Avg 34.4M 39.6M 50.1M
Low 33.4M 38.4M 48.6M

Revenue Growth

Revenue Growth 202420252026
High
42.2%
19.5%
31.5%
Avg
36.7%
14.9%
26.5%
Low
32.7%
11.5%
22.8%

EPS Forecast

EPS 202420252026
High -0.01 - -
Avg -0.01 - -
Low -0.01 - -

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.